Table 1.
Clinical and Laboratory Characteristics on admission and quantitative CT parameters in univariate logistic regression analysis.
| Clinical Deterioration or Death | ||||
|---|---|---|---|---|
| N | Yes (n = 85) | No (n = 238) | p Value | |
| Clinical characteristics | ||||
| Age, years | 323 | 66.48 (±14.45) | 64.77 (±15.21) | 0.15 |
| Male sex: N (%) | 323 | 56 (65.88) | 138 (57.98) | 0.02 |
| Onset of symptoms | 300 | 7.73 (±5.21) | 8.54 (±5.15) | 0.24 |
| Hypertension: N (%) | 323 | 39 (45.88) | 110 (46.22) | 0.96 |
| Diabetes: N (%) | 323 | 35 (41.18) | 55 (23.11) | 0.002 |
| Heart disease: N (%) | 323 | 20 (23.53) | 26 (10.92) | 0.005 |
| COPD: N (%) | 323 | 6 (7.06) | 8 (3.36) | 0.16 |
| Chronic renal disease: N (%) | 323 | 15 (17.65) | 34 (14.21) | 0.46 |
| Immunodeficiency: N (%) | 323 | 24 (26.63) | 53 (22.75) | 0.22 |
| Laboratory results (mean ±SD) | ||||
| C-reactive protein, mg/L | 310 | 152.10 (±107.67) | 94.70 (±73.44) | <0.001 |
| Ferritin, ng/mL | 233 | 3185.90 (±11037) | 1366.76 (±2856.62) | 0.21 |
| D-Dimers, µg/mL | 257 | 3.59 (13.20) | 1.75 (±3.87) | 0.16 |
| Procalcitonin, ng/mL | 156 | 2.42 (±7.27) | 0.44 (±1.12) | 0.006 |
| LDH, IU/L | 194 | 480.22 (±177.88) | 398.89 (±149.63) | 0.004 |
| Lymphocytes, G/L | 317 | 0.9 (±0.65) | 1.00 (±1.08) | 0.44 |
| Neutrophils G/L | 317 | 6.6 (±4.25) | 5.13 (±2.7) | 0.001 |
| Neutrophils/Lymphocytes | 317 | 14.38 (±35.38) | 7.5 (±7.67) | 0.008 |
| CT characteristics | ||||
| IV Contrast material: N (%) | 323 | 36 (42.35) | 101 (42.44) | 0.99 |
| Volume % of all opacities | 323 | 37.48 (±21.47) | 22.63 (±17.01) | <0.001 |
| Volume % consolidation | 323 | 8.87 (±8.22) | 5.00 (±5.64) | <0.001 |